These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 11467592
1. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma. Moore AS, Cotter SM, Rand WM, Wood CA, Williams LE, London CA, Frimberger AE, L'Heureux DA. J Vet Intern Med; 2001; 15(4):348-54. PubMed ID: 11467592 [Abstract] [Full Text] [Related]
2. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma. Zemann BI, Moore AS, Rand WM, Mason G, Ruslander DM, Frimberger AE, Wood CA, L'Heureux DA, Gliatto J, Cotter SM. J Vet Intern Med; 1998; 12(6):465-70. PubMed ID: 9857340 [Abstract] [Full Text] [Related]
3. Treatment of canine lymphoma with COPLA/LVP. Boyce KL, Kitchell BE. J Am Anim Hosp Assoc; 2000; 36(5):395-403. PubMed ID: 10997514 [Abstract] [Full Text] [Related]
9. Efficacy and toxicosis of VELCAP-C treatment of lymphoma in cats. Hadden AG, Cotter SM, Rand W, Moore AS, Davis RM, Morrissey P. J Vet Intern Med; 2008; 22(1):153-7. PubMed ID: 18289303 [Abstract] [Full Text] [Related]
12. Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol. Simon D, Nolte I, Eberle N, Abbrederis N, Killich M, Hirschberger J. J Vet Intern Med; 2006; 20(4):948-54. PubMed ID: 16955821 [Abstract] [Full Text] [Related]
15. Phase II clinical trial of combination chemotherapy with dexamethasone for lymphoma in dogs. Greenberg CB, Boria PA, Borgatti-Jeffreys A, Raskin RE, Lucroy MD. J Am Anim Hosp Assoc; 2007; 43(1):27-32. PubMed ID: 17209082 [Abstract] [Full Text] [Related]
16. Early progression during or after cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy indicates poor outcome with rescue protocols in dogs with multicentric lymphoma. Parker AS, Burton JH, Curran KM, Wolf-Ringwall A, Thamm DH. J Vet Intern Med; 2024; 38(4):2282-2292. PubMed ID: 38961691 [Abstract] [Full Text] [Related]
17. Evaluation of an actinomycin-D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma. Siedlecki CT, Kass PH, Jakubiak MJ, Dank G, Lyons J, Kent MS. Can Vet J; 2006 Jan; 47(1):52-9. PubMed ID: 16536229 [Abstract] [Full Text] [Related]
18. Factors influencing first remission and survival in 145 dogs with lymphoma: a retrospective study. Baskin CR, Couto CG, Wittum TE. J Am Anim Hosp Assoc; 2000 Jan; 36(5):404-9. PubMed ID: 10997515 [Abstract] [Full Text] [Related]
19. Sequential low-dose rate half-body irradiation and chemotherapy for the treatment of canine multicentric lymphoma. Lurie DM, Gordon IK, Théon AP, Rodriguez CO, Suter SE, Kent MS. J Vet Intern Med; 2009 Jan; 23(5):1064-70. PubMed ID: 19627472 [Abstract] [Full Text] [Related]
20. Influence of asparaginase on a combination chemotherapy protocol for canine multicentric lymphoma. Jeffreys AB, Knapp DW, Carlton WW, Thomas RM, Bonney PL, Degortari A, Lucroy MD. J Am Anim Hosp Assoc; 2005 Jan; 41(4):221-6. PubMed ID: 15995158 [Abstract] [Full Text] [Related] Page: [Next] [New Search]